Please login to the form below

Not currently logged in
Email:
Password:

product launch

This page shows the latest product launch news and features for those working in and with pharma, biotech and healthcare.

EMA approves GSK’s triple COPD therapy

EMA approves GSK’s triple COPD therapy

The EU regulator cleared Trelegy (fluticasone furoate/umeclidinium/vilanterol) - considered to be the most important new product in the company’s ailing respiratory franchise - as a maintenance treatment in adults with ... GSK said in a statement that

Latest news

  • AZ gets early FDA green light for Imbruvica challenger AZ gets early FDA green light for Imbruvica challenger

    The new product - which will be sold in the US as Calquence - has been approved much earlier than expected, bringing forward a marketing battle with Johnson/AbbVie's big-selling Imbruvica ... The new product will launch with a list price of around $14,

  • GSK’s shingles vaccine Shingrix claims US approval GSK’s shingles vaccine Shingrix claims US approval

    Japan. The company says it intends to make the product available in the US shortly at a price of $280 per two-dose course, which is just a few dollars above ... GSK chief executive Emma Walmsley has said the treatments will see the company through a lean

  • Belgium's Ablynx enters the US market Belgium's Ablynx enters the US market

    Dan] brings many years of experience in setting up commercial organisations and leading multiple successful product launches in the USA. ... Commenting on his appointment, Mr Schneider added: "I am delighted to join Ablynx at this very important moment

  • Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

    The new product will be launched first in the UK and Germany, according to Merck, which developed the drug and whose Merck Serono unit will commercialise it in partnership with Pfizer ... For Merck the drug is part of a series of new products it hopes

  • Intercept hit hard as FDA issues Ocaliva safety notice Intercept hit hard as FDA issues Ocaliva safety notice

    Intercept Pharma has only had a few months to revel in its first product launch before a safety warning from the FDA knocked it back. ... Sales of the drug have grown steadily to reach $30m in the second quarter of 2017, and analysts have predicted that

More from news
Approximately 1 fully matching, plus 217 partially matching documents found.

Latest Intelligence

  • Effective sales performance Effective sales performance

    To take two extremes:. 1. New products are evaluated first by an individual trying a product. ... In short it is of no value to pursue laggard practices when you launch a new product, your targets should match the promotional focus at that stage of the

  • Positive disruption in business intelligence Positive disruption in business intelligence

    Three areas where insights-led tactics are emerging are in pre-launch awareness and advocacy; product differentiation; and market access. ... One pharmaceutical company, for example, studied the online conversations of nurses and pharmacists during its

  • Meetings Meetings

    For a product launch, it makes good sense to anticipate early on which person and agenda would provide the perfect fit and develop relationships to make this feasible.

  • Can big data give medical affairs an edge in strategic planning? Can big data give medical affairs an edge in strategic planning?

    For example, Medmeme’s product called Link enables medical affairs departments to link with the right scientific expert for the right endeavour and gather a wealth of information about them, such ... leading up to the launch of a new product.

  • Proving real-world value Proving real-world value

    Industry, payers and patients must, she says, partner to operationalise real-world evidence as intelligence to inform product innovation. ... If, when you launch a product, your ambition is to maximise sales, the development, research and commercial

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Hughes-Wilson brings in-depth market access and product launch expertise as well as a proven ability to develop and lead commercial planning efforts globally. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and

  • Alacrita appoints Anna Casse as MD Alacrita appoints Anna Casse as MD

    Life science consulting firm Alacrita has appointed Anna Casse as its new managing director - a role that will see her assume responsibility for Alacrita Europe and help build its European Launch ... I am looking forward to driving further growth in the

  • Hanover Health bolsters PR leadership team Hanover Health bolsters PR leadership team

    Davies moves to Hanover Health from Tonic Life Communications where he was a senior account director specialising in oncology and neurology product communications, having first joined as an account director in ... 2011. She brings experience in pre- and

  • Dr Andrew Webber joins Life Healthcare Communications Dr Andrew Webber joins Life Healthcare Communications

    In his new in-house role, Dr Webber will be responsible for overseeing the global launch of a new product within the agency's service portfolio.

  • Former Boehringer diabetes marketing VP joins Gelesis Former Boehringer diabetes marketing VP joins Gelesis

    Dr Pass brings over 20 years of commercial expertise in the diabetes and metabolics areas among others to Gelesis, and takes on responsibility for all business development and product commercialisation, including ... Yishai Zohar, chief executive officer

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    However, as investment grows and organisations expand with diverse product portfolios, the market is also predicted to become more competitive and complex.More than  five-and-a-half million people  in ... The pharma giant’ s aim was to acquire the

  • Commercial innovation in biotech organisations

    Commercial innovation in biotech organisations. Blue Latitude Health speaks to Salma Jutt Vice President of US Marketing and Head of Commercial Innovation at a biotech specialising in treating weight loss and obesity. Image: Salma Jutt, Vice

  • Investigator meetings deconstructed

    Investigator meetings can be key to the success of a clinical trial in the roadmap to a market smashing product launch. ... Ashfield Meeting &Events continues to strive for new and innovative ways to keep your audience engaged and ensure the eventual

  • OUTiCO Case Study - Product Launch

    OUTiCO Case Study - Product Launch. POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS! ... CHALLENGE. New product launch. Limited market access capabilities in priority CCG/Health Boards.

  • An eye-catching product launch for lens manufacturer Rayner

    An eye-catching product launch for lens manufacturer Rayner. A case study by Create Health. ... PROJECT SCOPE. Fully integrated product launch campaign. Salesforce toolkit. Exhibition stand with performing artists.

More from PMHub
Approximately 5 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics